vendredi 8 septembre 2017
U.S. FDA warns of problems with EpiPen manufacturing plant
U.S. regulator tells maker of the EpiPen injector device that serious component and product failures have been associated with patient deaths and severe illness.
Related Posts:
Indigenous maternal health program aims to address inequality of health care- Zika virus hit earlier than thought in Brazil, Florida, genome tests reveal
- More people with Alzheimer's dying at home in U.S., CDC finds
- 'It is a crisis': A father's mission to save drug-addicted teens from dying
- Cannabidiol reduces seizures in kids with severe form of epilepsy, trial shows
Articles
0 comments:
Enregistrer un commentaire